Sort   by:  
 Page size 
GenomicsSarcophilus harrisii isolate:DFT1 1426
Cathelicidin-treated Tasmanian devil facial tumour (DFT1) 1426 cells
PRJNA970848 | ENA
GenomicsTwo of a kind: Transmissible Schwann cell cancers in the endangered Tasmanian devil
Comparative transcriptome analysis of DFT1, DFT2, and normal Tasmanian devil tissues
PRJEB28680 | ENA
GenomicsMesenchymal plasticity of devil facial tumour cells during in vivo vaccine and immunotherapy trials
Serial biopsies from experimentally-induced devil facial tumour 1 (DFT1) in three Tasmanian devils were analysed by single-read RNA sequencing. Two of the Tasmanian devils were previously immunised, providing unique 'cases' that could be analysed to understand DFT1 growth under tumour-specific press...
PRJEB40422 | ENA
ProteomicsTwo of a kind: Transmissible Schwann cell cancers in the endangered Tasmanian devil.
Devil facial tumour disease 1 and 2 (DFT1 and DFT2) are two genetically distinct transmissible cancers endangering the survival of the Tasmanian devil (Sarcophilus harrisii). DFT1 first arose from a cell of the Schwann cell lineage, however, the tissue-of-origin of the recently discovered DFT2 cance...
ORGANISM(S): Sarcophilus harrisii 
2019-08-06 | PXD011209 | Pride
Tasmanian devil Swath Devil facial tumour disease Proteomics 
GenomicsSarcophilus harrisii
Tasmanian devil (Sarcophilus harrisii) RNA-seq in imiquimod-treated devil facial tumour 1 (DFT1) cells
PRJNA416378 | ENA
ProteomicsProteomic analysis of Tasmanian devil facial tumour disease
The Tasmanian devil is the only mammalian species harbouring two lineages of contagious cancer within its population. This dataset represents the proteomics analysis of DFT1, DFT2 and SALEM lines.
ORGANISM(S): Sarcophilus harrisii 
2021-09-09 | PXD021784 | Pride
Dft2 Contagious cancer Devil facial tumour 1 Devil facial tumour 2 Sarcophilus harrisii Tasmanian devil Dft1 
GenomicsGenomes of Tasmanian devil transmissible cancers DFT1, DFT2 and normal animals.
The origins and vulnerabilities of two transmissible cancers in Tasmanian devils (2018).
PRJEB21902 | ENA
ProteomicsPassage of transmissible cancers in the Tasmanian devil is due to a dominant, shared peptide motif and a limited repertoire of MHC-I allotypes
Transmissible cancers are spread via the passage of malignant cells. The survival of the Tasmanian devil, the largest marsupial carnivore, is threatened by two independent transmissible cancers, devil facial tumour (DFT) 1 and devil facial tumour 2 (DFT2). To aid the development of a peptide vaccine...
ORGANISM(S): Sarcophilus harrisii 
2021-02-08 | PXD020614 | Pride
Contagious cancer Mhc Marsupial Transmissible cancer Tasmanian devil Immunopeptidome 
GenomicsRegulation of MHC-I and MHC-II expression by CIITA in transmissible devil facial tumour cells
Transcriptomic analysis of DFT1 and DFT2 cells with overexpression of CIITA
PRJEB45867 | ENA
UnknownEvolution and lineage dynamics of a transmissible cancer in Tasmanian devils.
Not available
S-EPMC7685465 | biostudies-literature
Sort   by:  
 Page size